Table 3 Pre-procedural Imaging Characteristics between Responders and Non-responders.
Responder (n = 50) | Non-responder (n = 36) | P value | |
|---|---|---|---|
Sorafenib usage | 13 (32.5%) | 5 (20.8%) | 0.312 |
Pre-procedural Imaging Characteristics | |||
APHE | 0.982 | ||
Absent | 14 (28.0%) | 10 (27.8%) | |
Present | 36 (72.0%) | 26 (72.2%) | |
Washout on portal venous phase | 0.400 | ||
Absent | 10 (20.0%) | 10 (27.8%) | |
Present | 40 (80.0%) | 26 (72.2%) | |
Capsule | 0.421 | ||
Absent | 35 (70.0%) | 28 (77.8%) | |
Present | 15 (30.0%) | 8 (22.2%) | |
Tumor morphology | 0.063 | ||
Well-defined | 41 (82.0%) | 23 (63.9%) | |
Infiltrative | 9 (18.0%) | 13 (36.1%) | |
Cystic degeneration | 0.657 | ||
Absent | 31 (62.0%) | 24 (66.7%) | |
Present | 19 (38.0%) | 12 (33.3%) | |
Macroscopic vessel involvement | 0.595 | ||
Absent | 14 (28.0%) | 12 (33.3%) | |
Present | 36 (72.0%) | 24 (66.7%) | |
Exophytic growth | 0.803 | ||
Absent | 40 (80.0%) | 28 (77.8%) | |
Present | 10 (20.0%) | 8 (22.2%) | |
Intra-hepatic vascular shunt | 0.004* | ||
Absent | 35 (70.0%) | 14 (38.9%) | |
Present | 15 (30.0%) | 22 (61.1%) | |
Angiographic Characteristics | |||
Feeding artery diameter | 0.865 | ||
≤microcatheter | 9 (18.0%) | 7 (19.4%) | |
>microcatheter | 41 (82.0%) | 29 (80.6%) | |
Number of supplying artery* | 0.934 | ||
Single | 42 (84.0%) | 30 (83.3%) | |
Multiple | 8 (16.0%) | 6 (16.7%) | |
Vascular lake phenomenon (VLP) | 0.037* | ||
Absent | 35 (70.0%) | 32 (88.9%) | |
Present | 15 (30.0%) | 4 (11.1%) | |
HTE on CBCT | <0.001* | ||
Yes | 40 (80.0%) | 6 (16.7%) | |
No | 10 (20.0%) | 30 (83.3%) | |
Residual tumor blush | <0.001* | ||
No | 28 (56.0%) | 3 (8.3%) | |
Yes | 22 (44.0%) | 33 (91.7%) | |
Sub-stasis endpoint | 0.720 | ||
No | 4 (8.0%) | 5 (13.9%) | |
Yes | 46 (92.0%) | 31 (86.1%) | |
